Gardasil 9 regulatory update

FDA approved Merck’s Gardasil 9 HPV vaccine for use in males ages 16-26. The recombinant HPV vaccine is already marketed in males ages 9-15 and females ages 9-26 to prevent anal cancer caused by HPV t...